X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3231) 3231
Book Review (595) 595
Publication (158) 158
Book Chapter (18) 18
Magazine Article (12) 12
Conference Proceeding (8) 8
Dissertation (2) 2
Paper (2) 2
Reference (2) 2
Web Resource (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2814) 2814
humans (2592) 2592
homocysteine (1754) 1754
hyperhomocysteinemia (1749) 1749
male (1733) 1733
female (1679) 1679
homocysteine - blood (1391) 1391
middle aged (1232) 1232
risk factors (1121) 1121
adult (1006) 1006
aged (879) 879
hyperhomocysteinemia - complications (863) 863
plasma homocysteine (634) 634
vascular-disease (628) 628
hyperhomocysteinemia - drug therapy (615) 615
hyperhomocysteinemia - blood (573) 573
animals (499) 499
folic acid (489) 489
folate (447) 447
folic acid - therapeutic use (426) 426
cardiovascular-disease (421) 421
folic-acid (416) 416
atherosclerosis (413) 413
peripheral vascular disease (377) 377
risk factor (354) 354
disease (353) 353
folic acid - blood (348) 348
methylenetetrahydrofolate reductase (348) 348
risk-factor (318) 318
oxidative stress (317) 317
risk (315) 315
homocysteine - metabolism (292) 292
vitamin b 12 - blood (281) 281
hyperhomocysteinemia - genetics (277) 277
abridged index medicus (273) 273
urology & nephrology (270) 270
aged, 80 and over (261) 261
folic acid - administration & dosage (261) 261
case-control studies (259) 259
methylenetetrahydrofolate reductase - genetics (257) 257
hyperhomocysteinemia - metabolism (249) 249
cardiovascular disease (248) 248
hyperhomocysteinemia - epidemiology (247) 247
hematology (246) 246
medicine, general & internal (246) 246
cardiac & cardiovascular systems (245) 245
vitamin b (245) 245
hyperhomocysteinemia - etiology (240) 240
nutrition & dietetics (233) 233
adolescent (228) 228
metabolism (228) 228
prospective studies (225) 225
mutation (223) 223
treatment outcome (221) 221
rats (220) 220
dietary supplements (218) 218
prevalence (218) 218
thrombosis (213) 213
stroke (212) 212
hyperhomocysteinemia - physiopathology (208) 208
physiological aspects (206) 206
biomarkers - blood (205) 205
clinical neurology (201) 201
genotype (201) 201
cardiovascular diseases - etiology (200) 200
vitamin b 12 - therapeutic use (199) 199
health aspects (197) 197
myocardial-infarction (194) 194
hyperhomocysteinemia - diagnosis (191) 191
analysis (182) 182
kidney failure, chronic - therapy (181) 181
neurosciences (181) 181
research (178) 178
mice (177) 177
methionine (176) 176
renal dialysis (175) 175
endothelial dysfunction (174) 174
mortality (172) 172
care and treatment (169) 169
plasma (167) 167
endocrinology & metabolism (166) 166
vitamin b complex - therapeutic use (163) 163
hypertension (158) 158
biochemistry & molecular biology (157) 157
cardiovascular diseases (157) 157
cross-sectional studies (152) 152
medicine, research & experimental (148) 148
plasma total homocysteine (147) 147
homocystine (146) 146
kidney failure, chronic - blood (146) 146
vitamin b12 (146) 146
polymorphism, genetic (145) 145
stage renal-disease (144) 144
time factors (143) 143
follow-up studies (142) 142
medicine & public health (142) 142
risk-factors (139) 139
metaanalysis (138) 138
therapy (138) 138
pharmacology & pharmacy (137) 137
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3042) 3042
French (41) 41
Spanish (36) 36
German (30) 30
Polish (25) 25
Italian (20) 20
Russian (17) 17
Chinese (15) 15
Japanese (8) 8
Portuguese (7) 7
Dutch (6) 6
Hungarian (5) 5
Croatian (2) 2
Czech (2) 2
Turkish (2) 2
Icelandic (1) 1
Korean (1) 1
Romanian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Stroke, ISSN 0039-2499, 01/2011, Volume 42, Issue 1, pp. 227 - 276
The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of ischemic stroke among survivors of... 
AHA scientific statements | Stroke | Stroke prevention | Transient ischemic attack | Ischemia | ACTIVATED PROTEIN-C | PATENT FORAMEN OVALE | transient ischemic attack | DENSITY-LIPOPROTEIN-CHOLESTEROL | LEFT-VENTRICULAR THROMBI | stroke | CLINICAL NEUROLOGY | AHA Scientific Statements | ischemia | FACTOR-V-LEIDEN | CLINICAL-CARDIOLOGY-SUBCOMMITTEE | SICKLE-CELL-ANEMIA | BODY-MASS INDEX | PERIPHERAL VASCULAR DISEASE | stroke prevention | INTERNAL CAROTID-ARTERY | INDEPENDENT RISK-FACTOR | Recurrence | Thrombophilia - therapy | Ischemic Attack, Transient - therapy | Embolism - therapy | Thrombosis - complications | Humans | Hyperhomocysteinemia - therapy | Male | Thrombophilia - complications | Ischemic Attack, Transient - complications | Atherosclerosis - therapy | Heart Diseases - complications | Cerebral Hemorrhage - therapy | Female | Platelet Aggregation Inhibitors - therapeutic use | Thrombosis - therapy | Platelet Aggregation Inhibitors - adverse effects | Pregnancy Complications, Cardiovascular - therapy | Stroke - prevention & control | Foramen Ovale, Patent - therapy | Embolism - complications | Anemia, Sickle Cell - complications | Risk Factors | Anticoagulants - therapeutic use | Atherosclerosis - complications | Anticoagulants - adverse effects | Evidence-Based Medicine | Pregnancy | Anemia, Sickle Cell - therapy | Stroke - etiology | Heart Diseases - therapy | Foramen Ovale, Patent - complications | Cerebral Hemorrhage - complications | Hyperhomocysteinemia - complications | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2004, Volume 350, Issue 26, pp. 2673 - 2681
Journal Article
Journal Article
American Journal of Physiology - Cell Physiology, ISSN 0363-6143, 07/2012, Volume 303, Issue 1, pp. 41 - 51
Hydrogen sulfide (H2S) has recently been identified as a regulator of various physiological events, including vasodilation, angiogenesis, antiapoptotic, and... 
Hydrogen sulfide | Cystathionine γ-lyase | Cystathionine β-synthase | 3-mercaptopyruvate sulfurtransferase | Mitophagy | homocysteine | cystathionine gamma-lyase | OXIDATIVE STRESS | PHYSIOLOGY | ENDOTHELIAL DYSFUNCTION | DIABETIC-NEPHROPATHY | ENDOPLASMIC-RETICULUM STRESS | SMOOTH-MUSCLE-CELL | HYDROGEN-SULFIDE | CELL BIOLOGY | MATRIX METALLOPROTEINASES | mitophagy | hydrogen sulfide | EXTRACELLULAR-MATRIX | cystathionine beta-synthase | TIMP-1 EXPRESSION | Hydrogen Sulfide - metabolism | Genetic Therapy | Vascular Endothelial Growth Factor A - biosynthesis | Reactive Oxygen Species - metabolism | Hyperhomocysteinemia - therapy | Hyperhomocysteinemia - metabolism | Cystathionine gamma-Lyase - metabolism | Homocysteine - metabolism | Hypertension, Renovascular - genetics | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Forkhead Transcription Factors - metabolism | Renal Artery - metabolism | Cystathionine gamma-Lyase - genetics | Cystathionine beta-Synthase - genetics | Proto-Oncogene Proteins c-akt - metabolism | Organ Culture Techniques | Endostatins - biosynthesis | Mice, Inbred C57BL | Cells, Cultured | Sulfurtransferases - genetics | Hypertension, Renovascular - therapy | Cystathionine beta-Synthase - metabolism | Matrix Metalloproteinase 13 - metabolism | Animals | Hyperhomocysteinemia - genetics | Mice | Forkhead Box Protein O3 | Platelet Endothelial Cell Adhesion Molecule-1 - biosynthesis | Vascular System Injuries | Sulfurtransferases - metabolism | Index Medicus | cystathionine γ-lyase | cystathionine β-synthase
Journal Article
Circulation, ISSN 0009-7322, 03/1999, Volume 99, Issue 9, pp. 1156 - 1160
Background-Hyperhomocysteinemia is a major and independent risk factor for vascular disease. The mechanisms by which homocysteine promotes atherosclerosis are... 
Antoxidants | Arteriosclerosis | Nitric oxide | Blood flow | Endothelium | endothelium | nitric oxide | CARDIAC & CARDIOVASCULAR SYSTEMS | INDUCED ARTERIOSCLEROSIS | RISK FACTOR | INJURY | HUMANS | HYPERHOMOCYST(E)INEMIA | arteriosclerosis | ARTERIES | antoxidants | DISEASE | NITRIC-OXIDE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | blood flow | PLASMA HOMOCYSTEINE | DILATATION | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2013, Volume 8, Issue 9, pp. e74155 - e74155
The management of recurrent pregnancy loss (RPL) still remains a great challenge, and women with polycystic ovarian syndrome (PCOS) are at a greater risk for... 
POLYCYSTIC-OVARY-SYNDROME | CONTROLLED-TRIAL | PLUS HEPARIN | INSULIN-RESISTANCE | MULTIDISCIPLINARY SCIENCES | THROMBOPHILIA | 1ST TRIMESTER | COMPLICATIONS | PREGNANCY LOSS | PLASMA HOMOCYSTEINE | ANTIPHOSPHOLIPID SYNDROME | Abortion, Habitual - pathology | Hyperhomocysteinemia - pathology | Prospective Studies | Obesity - drug therapy | Obesity - complications | Humans | Live Birth | Risk Factors | Insulin Resistance | Anticoagulants - therapeutic use | Treatment Outcome | Heparin, Low-Molecular-Weight - therapeutic use | Hyperhomocysteinemia - drug therapy | Obesity - pathology | Pregnancy | Polycystic Ovary Syndrome - complications | Polycystic Ovary Syndrome - drug therapy | Abortion, Habitual - drug therapy | Adult | Female | Aspirin - therapeutic use | Drug Therapy, Combination | Polycystic Ovary Syndrome - pathology | Hyperhomocysteinemia - complications | Prevention | Obesity | Care and treatment | Aspirin | Stein-Leventhal syndrome | Analysis | Insulin resistance | Heparin | Drug therapy, Combination | Miscarriage | Reproductive health | Therapy | Pregnancy complications | Biology | Abortion | Molecular weight | Body mass index | Salvage | Predictive control | Anticoagulants | Subpopulations | Polycystic ovary syndrome | Spontaneous abortion | Regression analysis | Insulin | Thrombosis | Medicine | Womens health | Infertility | Health risk assessment | Homocysteine | Index Medicus
Journal Article